# Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms

> **NCT04943783** · NA · UNKNOWN · sponsor: **Beijing Neurosurgical Institute** · enrollment: 40 (estimated)

## Conditions studied

- Dissecting Aneurysm of Cerebral Artery
- Intramural Hematomas
- Inflammation Vascular

## Interventions

- **DRUG:** Atorvastatin 20mg

## Key facts

- **NCT ID:** NCT04943783
- **Lead sponsor:** Beijing Neurosurgical Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-01
- **Primary completion:** 2022-01-01
- **Final completion:** 2022-07-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04943783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04943783, "Atorvastatin in the TREATment of Intracranial Unruptured VertebroBasilar Dissecting Aneurysms". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04943783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*